102 related articles for article (PubMed ID: 26436906)
1. Targeted α therapy for cancer: where we are today and where we are heading.
Melville G
Future Oncol; 2015 Nov; 11(22):3065-7. PubMed ID: 26436906
[No Abstract] [Full Text] [Related]
2. Radioimmunotherapy with α-particle-emitting radionuclides.
Seidl C
Immunotherapy; 2014; 6(4):431-58. PubMed ID: 24815783
[TBL] [Abstract][Full Text] [Related]
3. Clinical trials of targeted alpha therapy for cancer.
Allen BJ
Rev Recent Clin Trials; 2008 Sep; 3(3):185-91. PubMed ID: 18782076
[TBL] [Abstract][Full Text] [Related]
4.
Sathekge M; Knoesen O; Meckel M; Modiselle M; Vorster M; Marx S
Eur J Nucl Med Mol Imaging; 2017 Jun; 44(6):1099-1100. PubMed ID: 28255795
[No Abstract] [Full Text] [Related]
5. Potential and pitfalls of therapy with alpha-particles.
Welch MJ
J Nucl Med; 2005 Aug; 46(8):1254-5. PubMed ID: 16085579
[No Abstract] [Full Text] [Related]
6. The promise of targeted {alpha}-particle therapy.
Mulford DA; Scheinberg DA; Jurcic JG
J Nucl Med; 2005 Jan; 46 Suppl 1():199S-204S. PubMed ID: 15653670
[TBL] [Abstract][Full Text] [Related]
7. Targeted α-Therapy.
Brechbiel MW
Cancer Biother Radiopharm; 2020 Aug; 35(6):397. PubMed ID: 32503377
[No Abstract] [Full Text] [Related]
8. Global comparison of targeted alpha vs targeted beta therapy for cancer: In vitro, in vivo and clinical trials.
Marcu L; Bezak E; Allen BJ
Crit Rev Oncol Hematol; 2018 Mar; 123():7-20. PubMed ID: 29482781
[TBL] [Abstract][Full Text] [Related]
9. Alpha-emitters for immuno-therapy: a review of recent developments from chemistry to clinics.
Huclier-Markai S; Alliot C; Varmenot N; Cutler CS; Barbet J
Curr Top Med Chem; 2012; 12(23):2642-54. PubMed ID: 23339760
[TBL] [Abstract][Full Text] [Related]
10. Where Do We See Alpha Emitters in Clinical Practice? A Radiation Oncology Perspective.
O'Sullivan JM
J Med Imaging Radiat Sci; 2019 Dec; 50(4S1):S31-S33. PubMed ID: 31427257
[TBL] [Abstract][Full Text] [Related]
11. Control of prostate cancer spheroid growth using 213Bi-labeled multiple targeted alpha radioimmunoconjugates.
Wang J; Abbas Rizvi SM; Madigan MC; Cozzi PJ; Power CA; Qu CF; Morgenstern A; Apostolidis C; Russell PJ; Allen BJ; Li Y
Prostate; 2006 Dec; 66(16):1753-67. PubMed ID: 16955401
[TBL] [Abstract][Full Text] [Related]
12. An Appendix of Radionuclides Used in Targeted Alpha Therapy.
Ferrier MG; Radchenko V
J Med Imaging Radiat Sci; 2019 Dec; 50(4 Suppl 1):S58-S65. PubMed ID: 31427258
[No Abstract] [Full Text] [Related]
13. Tumour anti-vascular alpha therapy: a mechanism for the regression of solid tumours in metastatic cancer.
Allen BJ; Raja C; Rizvi S; Song EY; Graham P
Phys Med Biol; 2007 Jul; 52(13):L15-9. PubMed ID: 17664565
[TBL] [Abstract][Full Text] [Related]
14. Targeted alpha therapy with 213Bi.
Morgenstern A; Bruchertseifer F; Apostolidis C
Curr Radiopharm; 2011 Oct; 4(4):295-305. PubMed ID: 22202152
[TBL] [Abstract][Full Text] [Related]
15. Can α-radioimmunotherapy increase efficacy for the systemic control of cancer?
Allen BJ
Immunotherapy; 2011 Apr; 3(4):455-8. PubMed ID: 21463184
[No Abstract] [Full Text] [Related]
16. A comparative evaluation of Ac225 vs Bi213 as therapeutic radioisotopes for targeted alpha therapy for cancer.
Allen BJ
Australas Phys Eng Sci Med; 2017 Jun; 40(2):369-376. PubMed ID: 28342027
[TBL] [Abstract][Full Text] [Related]
17. Targeted Radiotherapy with Alpha-Particle Emitting Radionuclides Seminar, November 18, 2004, Cracow, Poland.
Zalutsky MR; Petelenz B
Nucl Med Rev Cent East Eur; 2004; 7(2):195. PubMed ID: 15968616
[No Abstract] [Full Text] [Related]
18. Targeted alpha-therapy for control of micrometastatic prostate cancer.
Li Y; Russell PJ; Allen BJ
Expert Rev Anticancer Ther; 2004 Jun; 4(3):459-68. PubMed ID: 15161444
[TBL] [Abstract][Full Text] [Related]
19. [Alpha-radioimmunotherapy: a review of recent developments].
Supiot S; Thillays F; Rio E; Mahé MA; Barbet FJ; Kraeber-Bodéré F; Chérel M
Cancer Radiother; 2007 Sep; 11(5):252-9. PubMed ID: 17604673
[TBL] [Abstract][Full Text] [Related]
20. Radiolabeled antibody therapy of lymphomas.
Press OW; Appelbaum FR; Eary JF; Bernstein ID
Important Adv Oncol; 1995; ():157-71. PubMed ID: 7672803
[No Abstract] [Full Text] [Related]
[Next] [New Search]
